Advanced Decision Vectors (ADV), LLC has been awarded a Health and Human Services task order to provide contract support to Biomedical Advanced Research and Development Authority (BARDA), in the areas of contracting, project/program and portfolio management, and business support.
This award solidifies ADV’s contribution to the nation’s defense against chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID). To-date, BARDA has supported 52 FDA approvals for products addressing CBRN, PI, and EID threats.
“ADV is honored to support BARDA’s mission to improve efficiency and accelerate development of medical countermeasures to sustain our national security,” said David S. Harris, CEO. “As ADV strives to become the most trusted source in providing mission critical solutions to the government, this contract awards shows we are understand our customers’ needs and are putting the right people in place to meet them,” he continued.
About BARDA
Biomedical Advanced Research and Development Authority is part of the HHS Office of the Assistant Secretary for Preparedness and Response. BARDA supports the transition of medical countermeasures such as vaccines, drugs, and diagnostics from research through advanced development towards consideration for approval by the FDA and inclusion into the Strategic National Stockpile. For more information go to https://www.phe.gov/about/barda/Pages/default.aspx